title: Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation.
authors.forename: Anna D
authors.initials: AD
authors.lastname: Petropoulou
authors.forename: Marie
authors.initials: M
authors.lastname: Robin
authors.forename: Vanderson
authors.initials: V
authors.lastname: Rocha
authors.forename: Patricia
authors.initials: P
authors.lastname: Ribaud
authors.forename: Aliénor
authors.initials: A
authors.lastname: Xhaard
authors.forename: Imad
authors.initials: I
authors.lastname: Abboud
authors.forename: Régis
authors.initials: R
authors.lastname: Peffault de Latour
authors.forename: Gérard
authors.initials: G
authors.lastname: Socié
authors.forename: Marie-Noelle
authors.initials: MN
authors.lastname: Peraldi
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects*; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000209:etiology*; D015235:HLA-B Antigens / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000209:etiology*; D010996:Pleural Effusion / Q000000981:diagnostic imaging; D013902:Radiography, Thoracic; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D015235:HLA-B Antigens; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid